Because androgen-independent prostate cancers often become resistant to antiandrogens, we tested the effect of the antiandrogen flutamide on DHT-stimulated PSA mRNA levels in control and CAsE-PE cells. The gene discussed is KLK3; the disease is prostate cancer.